Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Total Intravenous Anaesthesia Using Remifentanil In Extracorporeal Shock Wave Lithotripsy (ESWL). Comparison of Two Dosages.

NCT01452880 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT01452880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01452880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Total Intravenous Anaesthesia Using Remifentanil In Extracorporeal Shock Wave Lithotripsy (ESWL). Comparison of Two Dosages.
Lead sponsor
University of Roma La Sapienza
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
July 31, 2010
Enrollment
228 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney calculi